SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-17-001438
Filing Date
2017-09-21
Accepted
2017-09-21 15:53:43
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 4428
  Complete submission text file 0001123292-17-001438.txt   5768
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Issuer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address
Keefer Jason (Reporting) CIK: 0001717590 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32966 | Film No.: 171095812